Literature DB >> 16354832

Short report: disease severity and outcome of melioidosis in HIV coinfected individuals.

Wirongrong Chierakul1, Vanaporn Wuthiekanun, Wipada Chaowagul, Premjit Amornchai, Allen C Cheng, Nicholas J White, Nicholas P J Day, Sharon J Peacock.   

Abstract

This study examined whether coinfection with HIV and Burkholderia pseudomallei leads to altered disease severity or outcome associated with melioidosis. Coinfection was detected in only 8 of 524 (1.5%) adults with melioidosis in northeast Thailand. Clinical presentation and acute outcome were similar in HIV-positive and HIV-negative patients.

Entities:  

Mesh：

Year:  2005        PMID： 16354832

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  14 in total

1.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 3.  Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.

Authors:  Ella M Meumann; Allen C Cheng; Linda Ward; Bart J Currie
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

4.  Observational study of adult respiratory infections in primary care clinics in Myanmar: understanding the burden of melioidosis, tuberculosis and other infections not covered by empirical treatment regimes.

Authors:  Clare E Warrell; Aung Pyae Phyo; Mo Mo Win; Alistair R D McLean; Wanitda Watthanaworawit; Myo Maung Maung Swe; Kyaw Soe; Htet Naing Lin; Yee Yee Aung; Chitmin Ko Ko; Cho Zin Waing; Kaung San Linn; Yadanar Phoo Wai Aung; Ne Myo Aung; Ni Ni Tun; David A B Dance; Frank M Smithuis; Elizabeth A Ashley
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-08-02       Impact factor: 2.184

5.  Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei.

Authors:  Sharon J Peacock; Herbert P Schweizer; David A B Dance; Theresa L Smith; Jay E Gee; Vanaporn Wuthiekanun; David DeShazer; Ivo Steinmetz; Patrick Tan; Bart J Currie
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

6.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

7.  Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei.

Authors:  Patrick N A Harris; Natkunam Ketheesan; Leigh Owens; Robert E Norton
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

8.  Clinical problem-solving. Beware of first impressions.

Authors:  Oluwaseun O Falade; Emmanuel S Antonarakis; Daniel R Kaul; Sanjay Saint; Patrick A Murphy
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

Review 9.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

10.  Global burden of melioidosis in 2015: a systematic review and data synthesis.

Authors:  Emma Birnie; Harjeet S Virk; Jelmer Savelkoel; Rene Spijker; Eric Bertherat; David A B Dance; Direk Limmathurotsakul; Brecht Devleesschauwer; Juanita A Haagsma; W Joost Wiersinga
Journal:  Lancet Infect Dis       Date:  2019-07-05       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.